Jamal Rana, MD(@JamalRanaMD) 's Twitter Profileg
Jamal Rana, MD

@JamalRanaMD

Northern Gov & Imm. Past President @CaliforniaACC | @CedarsSinai Alum | Preventive Cardiologist & Researcher @PermanenteDocs | Opinions own

ID:1379288939140325381

linkhttps://pubmed.ncbi.nlm.nih.gov/?term=Rana+js&sort=date calendar_today06-04-2021 04:25:05

3,6K Tweets

2,1K Followers

531 Following

Matthew Solomon(@MDSolomonMD) 's Twitter Profile Photo

Was my honor to present on use within at the Spring conference 2024, and to hear Maria Ansari speak on innovation to support @permanentedocs across KPNorthernCal. 2024

Was my honor to present on #AI use within #TPMG at the #APG Spring conference 2024, and to hear @MariaAnsariMD speak on innovation to support @permanentedocs across @kpnorcal. #APG2024
account_circle
Jamal Rana, MD(@JamalRanaMD) 's Twitter Profile Photo

🙏 ⁦nancyatheart⁩ for all you do ⁦American Heart Association⁩. We all miss Mr. Bernard Tyson, a passionate supporter of ⁦& patients with 💔. It was great to be with ⁦Rita Ng, MD FACC⁩ & represent at ❤️ Ball. ⁦Maria Ansari

🙏 ⁦@NancyatHeart⁩ for all you do ⁦@American_Heart⁩. We all miss Mr. Bernard Tyson, a passionate supporter of #AHA ⁦& patients with 💔. It was great to be with ⁦@misscalifornia0⁩ & represent #KaiserPermanente #TPMG at #BayArea ❤️ Ball. ⁦@MariaAnsariMD⁩
account_circle
Muthu Vaduganathan(@mvaduganathan) 's Twitter Profile Photo

: Need to broaden focus from slowing progression to to ↓ cardio-kidney risk at earlier stage

✅ Risk appreciable at glycemic thresholds <6.5%

✅ Greater population attributable risk than T2D

✅ Risk modifiable?
largely a CVOT of in prediabetes

#Prediabetes: Need to broaden focus from slowing progression to #T2D to ↓ cardio-kidney risk at earlier stage ✅ Risk appreciable at glycemic thresholds <6.5% ✅ Greater population attributable risk than T2D ✅ Risk modifiable? #SELECT largely a CVOT of #GLP1RA in prediabetes
account_circle
Jamal Rana, MD(@JamalRanaMD) 's Twitter Profile Photo

Nestled between rivers Rhône & Saone, Musee des Confluence in Lyon is a modern architectural masterpiece. One of its anthropology exhibits on ❤️ took me by surprise! knows how to do it I guess (sound on).

account_circle
Vass Vassiliou(@vass_vassiliou) 's Twitter Profile Photo

An excellent article that gives everything you’d want to know about Lp(a) from ASPC AJPC

How common is it? Risk factor or risk modifier? Shall i get tested? When to treat? What tx?

For me everyone should get it checked and tailor management

sciencedirect.com/science/articl…

An excellent article that gives everything you’d want to know about Lp(a) from @ASPCardio @AJPCardio How common is it? Risk factor or risk modifier? Shall i get tested? When to treat? What tx? For me everyone should get it checked and tailor management sciencedirect.com/science/articl…
account_circle
Jamal Rana, MD(@JamalRanaMD) 's Twitter Profile Photo

Benefits from heart-healthy lifestyle may be related to lowering biological age healio.com/news/cardiolog…

account_circle
John Kastelein(@JohnKastelein) 's Twitter Profile Photo

Could this be part of the explanation as to why FH patients can have a different clinical course wile rxposed to the same LDL-C levels ?

Could this be part of the explanation as to why FH patients can have a different clinical course wile rxposed to the same LDL-C levels ?
account_circle
Khurram Nasir(@khurramn1) 's Twitter Profile Photo

In societies where population health approaches are preferred, for appropriate and resource allocations, cannot think of any other test in primary prevention setting then testing to truly guide both individual and societal level management decisions

account_circle
Jamal Rana, MD(@JamalRanaMD) 's Twitter Profile Photo

European Atherosclerosis Society Dr Kavousi gave an excellent & comprehensive review of myriad of risk calculations in Europe & US. Also spoke about CAC. Was surprised to see CAC is still class 2b indication in European guidelines. ⁦SABOURETCardiologist⁩ ⁦Khurram Nasir

⁦@society_eas⁩ #Congress2024 Dr Kavousi gave an excellent & comprehensive review of myriad of risk calculations in Europe & US. Also spoke about CAC. Was surprised to see CAC is still class 2b indication in European guidelines. ⁦@SABOURETCardio⁩ ⁦@khurramn1⁩
account_circle